InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by DEMSKI MARTHA J, Director. Director active across 3 companies, notably Adamas Pharmaceuticals Inc. In total, 8 reports have been recorded. Total volume traded: €32k. The latest transaction was filed on 17 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations8 total
€15,26410,000 shares@ €1.5264100.0% of flow
Common Stock
SEC:0001209191-22-029782:0·
Ideal exit: 11 Feb 2023 (T+270)
026,586 shares0
Common Stock
SEC:0001140361-22-008672:0·
16,000 shares
Common Stock
SEC:0001328143-21-000087·
16,000 shares
Common Stock
SEC:0001328143-21-000087:0·
€8,4802,000 shares@ €4.2399100.0% of flow
Common Stock
SEC:0001328143-21-000063·
€8,4802,000 shares@ €4.239950.0% of flow
Common Stock
SEC:0001328143-21-000063:0·
05,000 shares0
Common Stock
SEC:0001328143-21-000055·
05,000 shares0
Common Stock
SEC:0001328143-21-000055:0·
8 of 8 declarations
About DEMSKI MARTHA J
Martha J. Demski is a Director at Adamas Pharmaceuticals Inc, ADMA BIOLOGICS, INC., and CHIMERIX INC. As a board member, she participates in governance and strategic decision-making for these companies. Her experience in the pharmaceutical sector allows her to make significant contributions to growth and innovation initiatives.
